Tramadol Hydrochloride Tablet, Extended Release
NDC Package 70518-0886-3

11-digit billing NDC: 70518088603 · Billing unit: EA · 60 EA per package
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Tramadol Hydrochloride tablets is tramadol hydrochloride extended-release tablet is indicated for the management of severe and persistent pain that requires an opioid analgesic and that cannot be adequately treated with alternative options, including immediate-release opioids. This formulation utilizes a tablet, extended release delivery system. Marketed by Remedyrepack Inc., this product is identified by NDC 70518-0886 and is authorized under FDA application ANDA200503.

Identification & Billing

NDC Package Code
70518-0886-3
Package Description
60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
Product Code
70518-0886
11-Digit Billing Format
70518088603
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
60 EA
RxNorm Crosswalk
  • RxCUI: 833711 - traMADol HCl 200 MG 24HR Extended Release Oral Tablet
  • RxCUI: 833711 - 24 HR tramadol hydrochloride 200 MG Extended Release Oral Tablet
  • RxCUI: 833711 - tramadol HCl 200 MG 24 HR Extended Release Oral Tablet

Clinical Specifications

Proprietary Name
Tramadol Hydrochloride
Non-Proprietary Name
Tramadol Hydrochloride
Substance Name
Tramadol Hydrochloride
Dosage Form
Tablet, Extended Release - A solid dosage form containing a drug which allows at least a reduction in dosing frequency as compared to that drug presented in conventional dosage form.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
TRAMADOL HYDROCHLORIDE 200 mg/1
Pharmacologic Class
Usage Information
Tramadol hydrochloride extended-release tablet is indicated for the management of severe and persistent pain that requires an opioid analgesic and that cannot be adequately treated with alternative options, including immediate-release opioids. Limitations of UseBecause of the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosages or duration, and persist over the course of therapy [see Warnings and Precautions ( 5.1)] , reserve opioid analgesics, including tramadol hydrochloride extended-release tablets for use in patients for whom alternative treatment options are ineffective, not tolerated or would be otherwise inadequate to provide sufficient management of pain. Tramadol hydrochloride extended-release tablet is not indicated as an as-needed (prn) analgesic.
DEA Schedule
Schedule IV (CIV) Substances

Regulatory & Marketing

Labeler Name
Remedyrepack Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA200503
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-04-2017
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (70518-0886). Click a package code to view its specific billing and regulatory data.

70518-0886-0
30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
70518-0886-1
30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
70518-0886-2
90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70518-0886-3 identifies a specific commercial package of 60 tablet, extended release in 1 bottle, plastic of Tramadol Hydrochloride, a human prescription drug labeled by Remedyrepack Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 60 billable units per package. This tablet, extended release is formulated for oral use and contains tramadol hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Remedyrepack Inc. on December 04, 2017. The current certification is valid through December 31, 2027.

How is this Remedyrepack Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70518088603. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
70518-0886-3
11-Digit CMS (5-4-2)
70518-0886-03

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.